Worldwide Membranous Nephropathy Treatment Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4354909
- 125 Pages
- March 2021
- Healthcare
Filmy nephropathy is a kidney condition that as well as can cause healthy protein in the pee and also influences the filter of the kidney, and might also decrease the functioning of the kidney function and can trigger swelling.
The worldwide membranous nephropathy therapy market is expected to expand at a significant price due to the boosting no. of kidney problems and also vulnerable senior citizen populace worldwide.
The membranous nephropathy therapy market is divided on the basis of kind, medicine class and also distribution network.
The influence of covid-19 on membranous nephropathy therapy market has actually begun to be really felt. the outbreak of this condition resulted in lockdowns across world which has actually slowed down the growth of lots of markets. filmy nephropathy therapy market is no different. nonetheless, the marketplace is expected to catch up and proliferate in the projection years.
Filmy nephropathy therapy market: vehicle drivers as well as restraints
The increase in kidney conditions globally as well as prone aging populace is expected to be the leading factors to drive the growth of the membranous nephropathy therapy market. in addition, ongoing research activities and also good regulative scenario related to membranous nephropathy are likewise expected to boost the filmy nephropathy market throughout the projection period.
However, the growth of international membranous nephropathy therapy market might be hindered by discontinuation of the medications paired with preference over other treatments.
Membranous nephropathy treatment market: review
Filmy nephropathy therapy market is anticipated to experience constant development throughout the projection duration due to climb in kidney disorders around the world.
Based upon therapy type, the marketplace is fractional right into primary and also second. main membranous nephropathy is expected to be the higher contributor of earnings is this section as it is much more usual as compared to additional filmy nephropathy.
Based upon drug class, the market is segmented intochlorambucil, cyclic peptides, tacrolimus, mycophenolatemofeti, alkylating representatives, cyclophosphamide l as well as others. alkylating representatives and also cyclophosphamide are anticipated to contribute highest income in this segment because of its effectiveness in treating the filmy nephropathy.
Based upon circulation network, market is segmented into retail pharmacy, medical facility drug store and online pharmacy.
Filmy nephropathy therapy market: regional-wiseoutlook
Geographically, themembranous nephropathy therapy marketis segmented into sevenregions viz.north America, southern Asia, eastern Asia, Europe, Latin America, oceaniaandmiddle east and Africa.
The the United States and Canada is expected to dominate the worldwide filmy treatment market due to boosting no. of hepatitis influenced populace, in addition to risinggeriatric populace. in addition, expanding medical care expenditure as well as rising need for technically innovative treatment is expected to improve the market in this area.
Europe is expected to have the second biggest market for worldwide membranous nephropathy therapy market as a result of aspects like accessibility of newer and advanced therapy facilities, rising competent medical professionals and growing requirement for a far better healthcare situation.
Eastern Asia is expected to observe a considerable development in the filmy nephropathy treatment market. on the various other hand, south Asia is expected to experience fastest development in the filmy nephropathy treatment market as a result of increasing frequency of persistent illness as well as infections.
Additionally, the increasing geriatric and person populace in nations like India as well as China is anticipated to be the significant chauffeurs in this region. climbing recognition regarding health and wellness and also availability of new treatment approaches is additionally expected to increase the growth of the market in south Asia.
In the center east and also Africa the marketplace development is anticipated to be restricted because of absence of awareness, limited gain access to as well as accessibility of treatment facilities, slow financial growth as well as underdeveloped infrastructure.
Membranous nephropathy therapy market: key gamers
Several of the players recognized in the membranous nephropathy treatment marketinclude:
Abbie. inc.
Astrazeneca plc.
F. hoffman- la roche ltd.
Fibrogen
Allergan plc.
Amgen inc
Pfizer inc.
Novartis. ag.
Apotex inc.
Teva pharma sectors ltd.
The record is a collection of first-hand details, qualitative and also quantitative analysis by sector analysts, inputs from industry experts as well as industry participants across the value chain.
The record gives extensive evaluation of parent market patterns, macro-economic indications and regulating aspects in addition to market attractiveness according to sectors. the report also maps the qualitative impact of various market elements on market sectors and also locations.
Market sections
Market dynamics
Market size
Supply & demand present trends/issues/challenges
Competitors & companies involved
Technology matrix
Worth chain
Regional evaluation of the filmy nephropathy treatment market record consists of
North America
Latin America
Europe
South Asia
Eastern Asia
Oceania
Middle east and also Africa
Membranous nephropathy therapy marketreport highlights:
Introduction of international medical care market
Advancement of the technology
Changing market dynamics in the sector
Extensive market division
Historical, existing and projected market dimension in terms of value
Current sector trends as well as growths
Competitive landscape
Techniques of principals and also items supplied
Prospective as well as particular niche sections, geographical areas showing appealing development
A neutral perspective on market performance
Essential information for market gamers to sustain as well as improve their market impact.
Filmy nephropathy treatment market: segmentation
Tentatively, the worldwide filmy nephropathy treatment markethas been segmented on the basis oftreatment type, drug class as well as distribution network.
Treatment kind
Main
Secondary
Drug class
Alkylating agents
Cyclophosphamide
Chlorambucil
Cyclic peptides
Tacrolimus
Mycophenolatemofetil
Others
Distribution network
Medical facility pharmacy
Retail pharmacy
On-line drug store
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Membranous Nephropathy Treatment by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Membranous Nephropathy Treatment Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Membranous Nephropathy Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Membranous Nephropathy Treatment Production from 2014-2020
4.3.1.2 North America Membranous Nephropathy Treatment Consumption from 2014-2020
4.3.1.3 North America Membranous Nephropathy Treatment Import and Export from 2014-2020
4.3.1.4 North America Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Membranous Nephropathy Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Membranous Nephropathy Treatment Production from 2014-2020
4.3.2.2 Europe Membranous Nephropathy Treatment Consumption from 2014-2020
4.3.2.3 Europe Membranous Nephropathy Treatment Import and Export from 2014-2020
4.3.2.4 Europe Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Membranous Nephropathy Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Membranous Nephropathy Treatment Production from 2014-2020
4.3.3.2 Asia-Pacific Membranous Nephropathy Treatment Consumption from 2014-2020
4.3.3.3 Asia-Pacific Membranous Nephropathy Treatment Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Membranous Nephropathy Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Membranous Nephropathy Treatment Production from 2014-2020
4.3.4.2 Latin America Membranous Nephropathy Treatment Consumption from 2014-2020
4.3.4.3 Latin America Membranous Nephropathy Treatment Import and Export from 2014-2020
4.3.4.4 Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Membranous Nephropathy Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Membranous Nephropathy Treatment Production from 2014-2020
4.3.5.2 Middle East & Africa Membranous Nephropathy Treatment Consumption from 2014-2020
4.3.5.3 Middle East & Africa Membranous Nephropathy Treatment Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Membranous Nephropathy Treatment Market from 2020-2026
7.1 Future Forecast of Global Membranous Nephropathy Treatment Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Membranous Nephropathy Treatment Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Membranous Nephropathy Treatment Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
422 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Membranous Nephropathy Treatment Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Membranous Nephropathy Treatment Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Membranous Nephropathy Treatment
Figure Type 2 of Membranous Nephropathy Treatment
Figure Type 3 of Membranous Nephropathy Treatment
Table Global Membranous Nephropathy Treatment Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Membranous Nephropathy Treatment Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Membranous Nephropathy Treatment
Figure Application 2 of Membranous Nephropathy Treatment
Figure Application 3 of Membranous Nephropathy Treatment
Table Global Membranous Nephropathy Treatment Production Value ($) by Regions
Table Global Membranous Nephropathy Treatment Production Value Share by Regions
Table Global Membranous Nephropathy Treatment Production by Regions
Table Global Membranous Nephropathy Treatment Production Share by Regions
Table Global Membranous Nephropathy Treatment Consumption by Regions
Table Global Membranous Nephropathy Treatment Consumption Share by Regions
Figure North America Membranous Nephropathy Treatment Production and Growth Rate from 2014-2020
Figure North America Membranous Nephropathy Treatment Consumption and Growth Rate from 2014-2020
Table North America Membranous Nephropathy Treatment Import and Export from 2014-2020
Table North America Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
Table North America Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
Table North America Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
Figure Europe Membranous Nephropathy Treatment Production and Growth Rate from 2014-2020
Figure Europe Membranous Nephropathy Treatment Consumption and Growth Rate from 2014-2020
Table Europe Membranous Nephropathy Treatment Import and Export from 2014-2020
Table Europe Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Europe Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Europe Membranous Nephropathy Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Membranous Nephropathy Treatment Production and Growth Rate from 2014-2020
Figure Asia-Pacific Membranous Nephropathy Treatment Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Membranous Nephropathy Treatment Import and Export from 2014-2020
Table Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
Figure Latin America Membranous Nephropathy Treatment Production and Growth Rate from 2014-2020
Figure Latin America Membranous Nephropathy Treatment Consumption and Growth Rate from 2014-2020
Table Latin America Membranous Nephropathy Treatment Import and Export from 2014-2020
Table Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Membranous Nephropathy Treatment Production and Growth Rate from 2014-2020
Figure Middle East & Africa Membranous Nephropathy Treatment Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Membranous Nephropathy Treatment Import and Export from 2014-2020
Table Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Membranous Nephropathy Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Membranous Nephropathy Treatment Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Membranous Nephropathy Treatment Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Membranous Nephropathy Treatment Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Membranous Nephropathy Treatment Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Membranous Nephropathy Treatment Production and Growth Rate Forecast by Types (2020-2026)
Table Global Membranous Nephropathy Treatment Consumption and Growth Rate Forecast by End-User/Applications (2020-2439)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
